Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion type Assertion NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_head.
- NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion description "[DCR2 was found positive in 81 and 33% normal, 46 and 10% nodular hyperplasia, 74 and 36% PIN tissues, 87 and 89% low-grade carcinomas, and 100 and 93% high-grade carcinomas]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_provenance.
- NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion evidence source_evidence_literature NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_provenance.
- NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion SIO_000772 16799475 NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_provenance.
- NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion wasDerivedFrom lhgdn-20090331 NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_provenance.
- NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_assertion wasGeneratedBy ECO_0000203 NP164083.RA550C9x9oOvj3u31GpApFZ_UZGKv1IwUSPP5l8EV6QIg130_provenance.